Supporting market access for a leading pharmaceutical company.
Szpirt & Company supported a leading international pharmaceutical company in strengthening its position and market access in Denmark. Through stakeholder mapping, strategic dialogue and engagement with insurance companies, we identified opportunities to integrate the client’s treatments into existing healthcare packages, potentially expanding patient access and creating new commercial opportunities.
Why this mattered.
The client, a leading international pharmaceutical company, was looking to strengthen its position in the Danish market and improve access to its treatments. The Danish healthcare market involves a complex network of public and private stakeholders, making market access dependent on understanding both regulatory and commercial conditions. At the same time, private health insurance represented an opportunity to broaden access by including pharmaceutical treatments and solutions in relevant healthcare packages.
Support market access and strengthen the company’s position in the Danish healthcare market.
How we responded.
Szpirt & Company supported the client with market access and strategic stakeholder engagement in Denmark. We worked to identify relevant stakeholders and establish dialogue with insurance companies and other key actors across the healthcare sector. A particular focus was placed on exploring opportunities for collaboration with insurance companies and supporting discussions around the inclusion of the client’s pharmaceutical solutions in existing healthcare packages.
What changed.
The engagement helped strengthen the client’s understanding and position within the Danish healthcare market and created new opportunities for market access. Through dialogue with insurance companies, we helped facilitate opportunities for the client’s solutions to be included in relevant healthcare packages, potentially increasing access for patients while creating new commercial opportunities for the pharmaceutical company.
Project completed